From Bargain To Balancing Act: Merck's Next Test Begins (Rating Downgrade) [Seeking Alpha]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Seeking Alpha
Future returns now depend on execution and pipeline delivery, not multiple expansion. Keytruda erosion may be slower than feared for MRK, but LOE still creates a major revenue hole. Extended growth helps, yet replacement needs to accelerate meaningfully. New products and the Prometheus Biosciences pipeline show promise but remain early-stage revenue streams. Several more quarters of scaling are needed before confidence in gap-filling is justified. Valuation now reflects quality and reduced tail risk. With margins strong and cash flow resilient, expectations should reset toward steady compounding, not another rapid rerating phase. PeopleImages/iStock via Getty Images In May 2025 , I had positioned Merck & Co. ( MRK ) as a defensive GARP play with visible cash flows and a long-dated optionality offsetting a key patent cliff. I had argued that the stock was This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck: Pipeline Building Despite The Light FY26 Guide, Major Momentum [Seeking Alpha]Seeking Alpha
- Merck & Co., Inc. (NYSE:MRK) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=MRK&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street ZeMarketBeat
- Merck & Co., Inc. (MRK): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Guggenheim from $122.00 to $140.00. They now have a "buy" rating on the stock.MarketBeat
- ????????:2032????66?5000??????????????(CAGR)8.1%??? [CNET News]CNET News
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/6/26 - Form 144
- 2/6/26 - Form 144
- 2/6/26 - Form 4
- MRK's page on the SEC website